Lorenza Rimassa· @LorenzaRimassa · X·· 2 天前评分70
正文 · 机器翻译
Zev Wainberg 展示了 #daraxonrasib 在既往治疗过的转移性 #PDAC 患者中 III 期 RASolute 302 研究的亚组分析，于 #ESMO26（第 1 部分）#ESMOAmbassadors @myESMO
269 浏览 · 6 赞 · 6 转发 · 0 回复
会议摘要
LBA82按 Proffered paper 1: Gastrointestinal tumour, upper digestive 对上
Daraxonrasib, a RAS(ON) multi-selective inhibitor vs chemotherapy in previously treated metastatic pancreatic adenocarcinoma (mPDAC): Additional subgroup analyses from the ph3 RASolute 302 study
https://esmocongress.esmo.org来源：Lorenza Rimassa · x.com